{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:07:36Z","timestamp":1778728056227,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Mutual Madrile\u00f1a","award":["P177122021"],"award-info":[{"award-number":["P177122021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"DOI":"10.1007\/s10875-026-01997-0","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:57:45Z","timestamp":1775728665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["First Case of TAP1 Deficiency with EBV B-Cell Lymphoma Treated with Cellular Immunotherapy"],"prefix":"10.1007","volume":"46","author":[{"given":"Francisco Javier","family":"Bermejo-Olivera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Velasco-Sidro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"\u00cd\u00f1iguez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Arroyo-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Enrique","family":"Pleguezuelo-Garrote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Serrano-Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Fern\u00e1ndez-Galv\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tycho","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"L\u00f3pez-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Revilla-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estela","family":"Paz-Artal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis M.","family":"Allende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Cabrera-Marante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"1","key":"1997_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","volume":"40","author":"A Bousfiha","year":"2020","unstructured":"Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 2020;40(1):66\u201381. https:\/\/doi.org\/10.1007\/s10875-020-00758-x.","journal-title":"J Clin Immunol"},{"issue":"5","key":"1997_CR2","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1172\/JCI5687","volume":"103","author":"H de la Salle","year":"1999","unstructured":"de la Salle H, Zimmer J, Fricker D, Angenieux C, Cazenave JP, Okubo M, et al. HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J Clin Invest. 1999;103(5):R9\u201313.","journal-title":"J Clin Invest"},{"key":"1997_CR3","doi-asserted-by":"crossref","unstructured":"Gadola SD, \u00d6m\u00fcr Ardeniz A, Cuapio JZ, Ljunggren HG. Inborn errors of immunity affecting the MHC class I pathway for antigen presentation. J Hum Immun (2025).","DOI":"10.70962\/jhi.20250029"},{"issue":"10","key":"1997_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/qjmed\/hci112","volume":"98","author":"J Zimmer","year":"2005","unstructured":"Zimmer J, Andres E, Donato L, Hanau D, Hentges F, de la Salle H. Clinical and immunological aspects of HLA class I deficiency. QJM. 2005;98(10):719\u201327.","journal-title":"QJM"},{"key":"1997_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1001\/archdermatol.2009.354","volume":"146","author":"A Espa\u00f1a","year":"2010","unstructured":"Espa\u00f1a A, Gonz\u00e1lez-Santesteban C, Mart\u00ednez-Mart\u00ednez L, Bauz\u00e1 A, de la Calle-Mart\u00edn O. A novel mutation in the TAP2 gene in bare lymphocyte syndrome: association with metastatic cutaneous squamous cell carcinoma. Arch Dermatol. 2010;146:96\u20138.","journal-title":"Arch Dermatol"},{"key":"1997_CR6","first-page":"290","volume":"2","author":"C Pottier","year":"2022","unstructured":"Pottier C, Kottler D, Picard-Dahan C, Deschamps L, Rosain J, Suarez F, et al. Granulomatose cutan\u00e9e secondaire \u00e0 un d\u00e9ficit en TAP1 trait\u00e9e par infliximabCutaneous granulomatosis secondary to TAP1 deficiency treated with infliximab. Ann Dermatol Venereol. 2022;2:290\u20134.","journal-title":"Ann Dermatol Venereol"},{"key":"1997_CR7","doi-asserted-by":"publisher","first-page":"1675097","DOI":"10.3389\/fimmu.2025.1675097","volume":"16","author":"S Haskologlu","year":"2025","unstructured":"Haskologlu S, Ikinciogullari A, Islamoglu C, Bal SK, Bayrakoglu D, Erdem S, Karahan ZC, Ardeniz O, Aytekin C, Heper A, Ceylaner S, Dogu F. Clinical and immunological spectrum of MHC class I deficiency: insights from a long-term cohort with two novel mutations. Front Immunol. 2025;16:1675097.","journal-title":"Front Immunol"},{"key":"1997_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1366840","volume":"15","author":"Q Wang","year":"2024","unstructured":"Wang Q, Su H, Han J, Yang J, Lin N. Case report: rubella virus-associated cutaneous granuloma in an adult with TAP1 deficiency. Front Immunol. 2024;15:1366840.","journal-title":"Front Immunol"},{"key":"1997_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clim.2017.01.011","volume":"178","author":"D Hanalioglu","year":"2017","unstructured":"Hanalioglu D, Ayvaz DC, Ozgur TT, van der Burg M, Sanal O, Tezcan I. A novel mutation in TAP1 gene leading to MHC class I deficiency: report of two cases and review of the literature. Clin Immunol. 2017;178:74\u20138.","journal-title":"Clin Immunol"},{"issue":"6","key":"1997_CR10","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.aller.2017.01.006","volume":"45","author":"A Tak Manesh","year":"2017","unstructured":"Tak Manesh A, Azizi G, Heydari A, Kiaee F, Shaghaghi M, Hossein-Khannazer N, et al. Epidemiology and pathophysiology of malignancy in common variable immunodeficiency? Allergol Immunopathol (Madr). 2017;45(6):602\u201315.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"3","key":"1997_CR11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.jaip.2018.10.049","volume":"7","author":"KM Harris","year":"2019","unstructured":"Harris KM, Davila BJ, Bollard CM, Keller MD. Virus-specific T cells: current and future use in primary immunodeficiency disorders. J Allergy Clin Immunol Pract. 2019;7(3):809\u201318.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1997_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00556","volume":"9","author":"LP McLaughlin","year":"2018","unstructured":"McLaughlin LP, Bollard CM, Keller MD. Adoptive T cell therapy for Epstein-Barr virus complications in patients with primary immunodeficiency disorders. Front Immunol. 2018;9:556.","journal-title":"Front Immunol"},{"issue":"5","key":"1997_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1200\/JCO.20.01709","volume":"39","author":"HE Heslop","year":"2021","unstructured":"Heslop HE, Sharma S, Rooney CM. Adoptive T-cell therapy for Epstein-Barr Virus-Related lymphomas. J Clin Oncol. 2021;39(5):514\u201324.","journal-title":"J Clin Oncol"},{"issue":"7809","key":"1997_CR14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alfoldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434\u201343.","journal-title":"Nature"},{"issue":"1","key":"1997_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12016-017-8666-8","volume":"54","author":"B Terziroli Beretta-Piccoli","year":"2018","unstructured":"Terziroli Beretta-Piccoli B, Mainetti C, Peeters MA, Laffitte E. Cutaneous granulomatosis: a comprehensive review. Clin Rev Allergy Immunol. 2018;54(1):131\u201346.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"1997_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23712","volume":"35","author":"J Palomares-Marin","year":"2021","unstructured":"Palomares-Marin J, Govea-Camacho LH, Araujo-Caballero V, Cazarez-Navarro G, Rodriguez-Preciado SY, Ortiz-Hernandez E, et al. Association between the TAP1 gene polymorphisms and recurrent respiratory papillomatosis in patients from Western Mexico: a pilot study. J Clin Lab Anal. 2021;35(4):e23712.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"1997_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000330335","volume":"223","author":"LY Chiam","year":"2011","unstructured":"Chiam LY, Verhagen MM, Haraldsson A, Wulffraat N, Driessen GJ, Netea MG, et al. Cutaneous granulomas in ataxia telangiectasia and other primary immunodeficiencies: reflection of inappropriate immune regulation? Dermatology. 2011;223(1):13\u20139.","journal-title":"Dermatology"},{"issue":"3","key":"1997_CR18","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s10875-020-00940-1","volume":"41","author":"JP Brooks","year":"2021","unstructured":"Brooks JP, Rice AJ, Ji W, Lanahan SM, Konstantino M, Dara J, et al. Uncontrolled Epstein-Barr virus as an atypical presentation of deficiency in ADA2 (DADA2). J Clin Immunol. 2021;41(3):680\u20133.","journal-title":"J Clin Immunol"},{"key":"1997_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10875-024-01856-w","volume":"45","author":"D Bhattarai","year":"2025","unstructured":"Bhattarai D, Banday AZ, Sharda S, Patra PK, Walter JE, Sullivan KE. Novel inherited N-terminus TAP1 variants and severe clinical manifestations- are genotype-phenotype correlations emerging? J Clin Immunol. 2025;45:63. https:\/\/doi.org\/10.1007\/s10875-024-01856-w.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1997_CR20","doi-asserted-by":"publisher","first-page":"e375","DOI":"10.1111\/pde.13676","volume":"35","author":"S Law-Ping-Man","year":"2018","unstructured":"Law-Ping-Man S, Toutain F, Rieux-Laucat F, Picard C, Kammerer-Jacquet S, Magerus-Chatinet A, et al. Chronic granulomatous skin lesions leading to a diagnosis of TAP1 deficiency syndrome. Pediatr Dermatol. 2018;35(6):e375\u20137.","journal-title":"Pediatr Dermatol"},{"key":"1997_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02404","volume":"10","author":"J Zimmer","year":"2019","unstructured":"Zimmer J. Alessandro Moretta and transporter associated with antigen processing (TAP) deficiency: on giant\u2019s shoulders. Front Immunol. 2019;10:2404.","journal-title":"Front Immunol"},{"key":"1997_CR22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/BF00395879","volume":"21","author":"H Maeda","year":"1985","unstructured":"Maeda H, Hirata R, Chen RF, Suzaki H, Kudoh S, Tohyama H. Defective expression of HLA class I antigens: A case of the bare lymphocyte without immunodeficiency. Immunogenetics. 1985;21:549\u201358.","journal-title":"Immunogenetics"},{"key":"1997_CR23","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S0190-9622(96)90091-2","volume":"35","author":"A Plebani","year":"1996","unstructured":"Plebani A, Monafo V, Cattaneo R, Carella G, Brugnoni D, Facchetti F, Battocchio S, Meini A, Notarangelo LD, Duse M, Ugazio AG. Defective expression of HLA class I and CD1a molecules in boy with Marfan-like phenotype and deep skin ulcers. J Am Acad Dermatol. 1996;35:814\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"1997_CR24","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/S0140-6736(99)04206-3","volume":"354","author":"HT Moins-Teisserenc","year":"1999","unstructured":"Moins-Teisserenc HT, Gadola SD, Cella M, Dunbar PR, Exley A, Blake N, Baykal C, Lambert J, Bigliardi P, Willemsen M, et al. Association of a syndrome resembling Wegener\u2019s granulomatosis with low surface expression of HLA class-I molecules. Lancet. 1999;354:1598\u2013603.","journal-title":"Lancet"},{"key":"1997_CR25","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1136\/bjo.2005.078097","volume":"89","author":"A de la Parissiadis","year":"2005","unstructured":"Parissiadis A, Dormoy A, Fricker D, Hanau D, de la Salle H, Cazenave J-P, Lenoble P, Donato L. Unilateral necrotising toxoplasmic retinochoroiditis as the main clinical manifestation of a peptide transporter (TAP) deficiency. Br J Ophthalmol. 2005;89:1661\u20132.","journal-title":"Br J Ophthalmol"},{"key":"1997_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.parint.2006.02.003","volume":"55","author":"F Dogu","year":"2006","unstructured":"Dogu F, Ikincio\u02d8 gullari A, Fricker D, Bozdo\u02d8 gan G, Aytekin C, Ileri M, Tezi\u00e7 T, Babacan E. and H. De La Salle. A novel mutation for TAP deficiency and its possible association with Toxoplasmosis. Parasitol Int 2006;55:219\u201322.","journal-title":"Parasitol Int"},{"key":"1997_CR27","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1002\/art.23675","volume":"58","author":"A de la Villa-Forte","year":"2008","unstructured":"Villa-Forte A, de la Salle H, Fricker D, Hentges F, Zimmer J. HLA class I deficiency syndrome mimicking Wegener\u2019s granulomatosis. Arthritis Rheum. 2008;58:2579\u201382.","journal-title":"Arthritis Rheum"},{"key":"1997_CR28","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.jaci.2016.06.029","volume":"138","author":"Y Gao","year":"2016","unstructured":"Gao Y, Arkwright PD, Carter R, Cazaly A, Harrison RJ, Mant A, Cant AJ, Gadola S, Elliott TJ, Khakoo SI, Williams AP. Bone marrow transplantation for MHC class I deficiency corrects T-cell immunity but dissociates natural killer cell repertoire formation from function. J Allergy Clin Immunol. 2016;138:1733\u2013e17362.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"1997_CR29","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","volume":"42","author":"SG Tangye","year":"2022","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, Klein C, Morio T, Oksenhendler E, Picard C, Puel A, Puck J, Sepp\u00e4nen MRJ, Somech R, Su HC, Sullivan KE, Torgerson TR, Meyts I. Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2022;42(7):1473\u2013507.","journal-title":"J Clin Immunol"},{"issue":"26","key":"1997_CR30","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1182\/blood-2018-03-785931","volume":"131","author":"CM Bollard","year":"2018","unstructured":"Bollard CM, Cohen JI. How i treat T-cell chronic active Epstein-Barr virus disease. Blood. 2018;131(26):2899\u2013905.","journal-title":"Blood"},{"key":"1997_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.798959","volume":"9","author":"A Szczawinska-Poplonyk","year":"2021","unstructured":"Szczawinska-Poplonyk A, Grzesk E, Schwartzmann E, Materna-Kiryluk A, Maldyk J. Case report: autoimmune lymphoproliferative syndrome vs. chronic active Epstein-Barr virus infection in children: a diagnostic challenge. Front Pediatr. 2021;9:798959.","journal-title":"Front Pediatr"},{"key":"1997_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239314","author":"CC Chen","year":"2020","unstructured":"Chen CC, Chang KC, Medeiros LJ, Lee JY. Hydroa vacciniforme and hydroa vacciniforme-like lymphoproliferative disorder: a spectrum of disease phenotypes associated with ultraviolet irradiation and chronic Epstein-Barr virus infection. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21239314.","journal-title":"Int J Mol Sci"},{"key":"1997_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1083215","volume":"10","author":"K Al-Akioui Sanz","year":"2023","unstructured":"Al-Akioui Sanz K, Echecopar Parente C, Ferreras C, Menendez Ribes M, Navarro A, Mestre C, et al. Familial CD45RA(-) T cells to treat severe refractory infections in immunocompromised patients. Front Med (Lausanne). 2023;10:1083215.","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"1997_CR34","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1128\/jvi.70.8.5357-5362.1996","volume":"70","author":"R Khanna","year":"1996","unstructured":"Khanna R, Burrows SR, Moss DJ, Silins SL. Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies. J Virol. 1996;70(8):5357\u201362.","journal-title":"J Virol"},{"key":"1997_CR35","doi-asserted-by":"publisher","first-page":"915986","DOI":"10.3389\/fimmu.2022.915986","volume":"13","author":"E Grzesk","year":"2022","unstructured":"Grzesk E, Koltan S, Dabrowska A, Urbanczyk A, Maldyk J, Malkowski B, et al. Case report: cellular therapy for Hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection. Front Immunol. 2022;13:915986.","journal-title":"Front Immunol"},{"issue":"9","key":"1997_CR36","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/s0198-8859(00)00156-7","volume":"61","author":"BC Godthelp","year":"2000","unstructured":"Godthelp BC, Van Eggermond MC, Van Tol MJ, Vossen JM, van den Elsen PJ. T cell immune reconstitution after allogeneic bone marrow transplantation in bare lymphocyte syndrome. Hum Immunol. 2000;61(9):898\u2013907. https:\/\/doi.org\/10.1016\/s0198-8859(00)00156-7.","journal-title":"Hum Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-026-01997-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-01997-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-01997-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:12:51Z","timestamp":1778724771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-026-01997-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1997"],"URL":"https:\/\/doi.org\/10.1007\/s10875-026-01997-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7188387\/v1","asserted-by":"object"}]},"ISSN":["1573-2592"],"issn-type":[{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Hospital La Princesa Ethics Committee consent (2021) for data\/photograph use; Hospital 12 de Octubre CI 04-1012 (2022) for genetic studies\/data use; and subsequent treatment-specific approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from the patient and the family.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Informed consent was obtained from the patient and he accepted to share the images in the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"52"}}